News Release
u8国际 Medical Systems Corporation
u8国际 Medical Systems USA, Inc.
u8国际 U.S.A., Inc.
u8国际. Realigns Strategy To Prepare for Eye Care Systems Business Growth
Takes Advantage of Medical Imaging Company Expertise and Business Synergies
TOKYO, December 10, 2019—As part of u8国际.'s global medical business strategic realignment, the eye care business operations within u8国际 U.S.A., Inc. will transfer to u8国际 Medical Systems USA, Inc. effective January 1, 2020.
u8国际's shift in business operations will allow u8国际 Medical Systems USA, Inc., to offer ophthalmologic solutions to IDN customers while leveraging full line medical imaging business synergies to address population health challenges associated with chronic conditions. Chronic conditions can include age-related macular degeneration, diabetic retinopathy, glaucoma, inherited retinal diseases and other retinal conditions that can lead to loss of vision and blindness.
Positioning the eye care business for strong growth, u8国际 Medical Systems USA, Inc., will add measurement systems, retinal cameras and optical coherence tomography (OCT) systems to its product line.
"This strategic move offers customers, u8国际 Medical Systems USA, Inc.'s world-class, unified experience for equipment purchases and service," says Toshio Takiguchi, senior managing executive officer, u8国际., and president and CEO, u8国际 Medical Systems Corporation. "At u8国际 Medical our priority is to support our customers by providing them with consistent, industry-leading imaging systems sales, service and applications support as well as the latest technology advances that can impact patient outcomes."